Düzen Selects Bruker´s MALDI Biotyper for Mass Spectrometry-based Molecular Microbial Identification
05 June 2012 - 11:26PM
Business Wire
At the 7th National Molecular and Diagnostic Microbiology
Congress in Ankara, Bruker announces an exclusive framework
agreement with Düzen (www.duzen.com.tr) in the area of molecular
microbial identification based on MALDI-TOF mass spectrometry.
Düzen is one of the leading private diagnostic laboratory groups in
Turkey, and Bruker is the leading provider of mass
spectrometry-based microorganism identification solutions
worldwide. Düzen Laboratories, a highly regarded clinical
diagnostics company for 38 years, is the pioneer in its field in
introducing new technologies into routine clinical use in Turkey.
In addition, Düzen also supports government and university funded
health programs, and is the contract service provider of several
embassies for visa applications.
Dr. Elvan Laleli-Sahin, Member of the
Board of Directors, Duzen. (Photo: Business Wire)
During an extensive evaluation study of the commercially
available MALDI-TOF based microorganism identification systems,
Bruker’s MALDI Biotyper solution repeatedly outperformed
other systems in both its analytical performance and easy to use
workflow. On this basis, Düzen decided to enter into an exclusive
long-term agreement with Bruker to equip its laboratories with the
market leading MALDI Biotyper system.
“We decided that the MALDI Biotyper is the most suitable
system based on its smart and intelligent workflows and IT
embedding features, and coupled with Bruker’s service and support
network significantly reduced the challenges of implementing a new
technology like MALDI-TOF into our daily routine workflow,”
commented Dr. G�rkem Yaman, Microbiology Specialist at Düzen.
Dr. Yaman commented further: “After successfully introducing a
revolutionary species identification workflow, Bruker’s team of
microbiologists are continuing to expand the horizons of MALDI-TOF
microbial applications, providing us with initial ideas on how to
detect particular resistance mechanisms with the MALDI
Biotyper. This means that MALDI-TOF based detection of
β-lactamases and carbapenemases activity is possible in less than
three hours, for some enzymes even within one hour. This approach
also can be applied to the analysis of positive blood cultures
using Bruker’s MALDI Sepsityper kit, obtaining information
both on the species and its possible resistance mechanisms within a
couple of hours. This may have a significant impact on the clinical
management of patients in Turkey.”
“When considering potential partners it is important for us to
identify not only the most reliable partner but one that fully
understands our needs and requirements. Bruker’s “Open Microbiology
Concept” permits us to use and connect different technologies of
our choice; this flexible approach compliments our own strategy and
concepts perfectly. The philosophies of both companies fit nicely
together and I am looking forward to expanding the cooperation into
other regions in the future,” concluded Dr. Elvan Laleli-Sahin,
Member of the Board of Directors, Düzen.
Dr. Guido Mix, Director of Microbiology at Bruker Daltonics,
added: “We are very pleased that after leading the MALDI-TOF-based
revolution for microbial identification, Bruker is now also leading
the integration of this new molecular method into the overall
microbiological workflow. Our efforts toward developing smart and
straightforward workflows for the daily microbiological routine of
labs are especially valued by our customers. Being able to offer
very robust mass spectrometer hardware and software, and proven
hands-on standard operating protocols, all backed-up by our
dedicated microbiology support specialists, makes Bruker a reliable
long-term partner.”
About the Bruker MALDI Biotyper
Bruker’s dedicated MALDI Biotyper solution
(www.bdal.com/maldibiotyper) enables molecular identification, and
taxonomical classification or dereplication of microorganisms like
bacteria, yeasts and fungi. Classification and identification of
microorganisms is achieved reliably and quickly using proteomic
fingerprinting by high-throughput MALDI-TOF mass spectrometry.
Applications include clinical routine microbial identification,
environmental and pharmaceutical analysis, taxonomical research,
food and consumer product safety and quality control, as well as
marine microbiology. Bruker’s robust MALDI Biotyper method requires
minimal sample preparation efforts and offers low consumables cost
per sample. The MALDI Biotyper is available in a research-use-only
version, as well as in an IVD-CE version according to EU directive
EC/98/79 in various European countries.
ABOUT BRUKER CORPORATION (NASDAQ: BRKR)
Bruker is a leading provider of high-performance scientific
instruments and solutions for molecular and materials research, as
well as for industrial and applied analysis. For more information:
www.bruker.com
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50300094&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024